Professor of Politics
Department of Political Economy
London WC2R 2LS
Telephone: +44 (0)20 7848 2300
Professor Brian Salter is Deputy Head of Department and responsible for the development and implementation of the Department's strategy. He is the Director of the Global Biopolitics Research Centre.
As a political scientist specialising in the analysis of public policy, Brian has studied the political forces at work in the policy arenas of education, health and, most recently, the life sciences. Here he is focusing on the politics of new health technologies and the international governance issues associated with the global competition between nation states for innovative advantage in the knowledge economies of the future.
Currently Brian is exploring the political challenges posed by the emergence of China, India and Brazil as the 'Rising Powers' in the global biomedical economy. Current research includes projects funded by the ESRC and the EU FP7 Programme. Closely associated with Brian's academic work is his role as policy adviser to government, funding agencies, professional and international bodies and ethical adviser to the European Framework Programmes.
An experienced flight instructor and flight examiner, Brian is the only professor in the UK to have flown a World War II Spitfire and crash landed a civilian aircraft at Williams Air Force Base in the United States.
- MA Public Policy
- Public Policy Doctoral Programme
Main Research Interests
- Global politics of innovation
- Governance of biomedicine
- China, India and the challenge to US hegemony in the bioeconomy
- Politics of bioethics
Recent Funded Research
ESRC Rising Powers Programme (2010-11) ‘Strategies of governance in global biomedical innovation: the impact of China and India’. (with Dr Alex Faulkner)
EU FP7 (2009-12).PEGASUS ‘Genetically modified animals. Science, utility and society.’ Workpackage on policy development and implementation.(with Nuria Vazquez Salat)
EU FP7 (2008-11).REMEDiE ‘Regenerative medicine in Europe: emerging needs and challenges in a global context’. Workpackage on state strategies.(with Dr Stuart Hogarth)
Wellcome Trust (2009-14). ‘From animal to human? Regulating inter-species embryos in a global ethical context’. Project within the London and Brighton Translational Ethics Centre.(with Dr Alison Harvey)
ESRC Stem Cell Programme (2005-08) ‘The global politics of human embryonic stem cell science’. (with Professor Catherine Waldby and Professor Herbert Gottweis)
Nine books and over 100 articles. Recent publications include:
Salter B and Salter C (forthcoming). Controlling new knowledge: genomic science, governance and the politics of bioinformatics. Social Studies of Science.
Salter B, Zhou Y and Datta S (2016): Governing new global health-care markets: the case of stem cell treatments, New Political Economy. Published online 1st July.
Salter B, Zhou Y, Datta S and Salter C (2016). Bioinformatics and the politics of innovation in the life sciences: science and the state in the United Kingdom, China and India. Science, Technology and Human Values. 1-34.
Salter B, Filippakou, Tapper T (2016). Expanding the English medical schools: The politics of knowledge control. London Review of Education. 14(1): 23-32
Salter, B., Zhou, Y., & Datta, S. (2015). Hegemony in the marketplace of biomedical innovation: Consumer demand and stem cell science. Social Science & Medicine 131: 156-163.
Salter B and Harvey B (2014). Creating problems in the governance of science: bioethics and human/animal chimeras. Science and Public Policy. 41(5): 685-696.
Salter B and Salter C (2013). Bioethical ambition, political opportunity and the European governance of patenting: the case of human embryonic stem cell science. Social Science and Medicine. 98: 286-292.
Harvey A and Salter B (2012). Governing the moral economy: animal engineering, ethics and the liberal government of science. Social Science and Medicine. 75: 193-199.
Harvey A and Salter B (2012). Anticipatory governance: bioethical expertise for human/animal chimeras. Science as Culture. 21(3): 291-313.
Vàzquez-Salat N, Salter B, Smets G, Houdebine LM (forthcoming 2012). The current state of GMO governance: Are we ready for GM animals? Biotechnology Advances.
Filippakou O, Salter B and Tapper E (2012). Higher Education as a System: The English Experience. Higher Education Quarterly. 66(1): 106–122
Salter B and Waldby C (2011). Biopolitics in China: an introduction. East Asia Science and Technology: An International Journal. 5(3): 287-90. [Special Issue]
Salter B and Faulkner A (2011). State strategies of governance in biomedical innovation: aligning conceptual approaches for understanding ‘Rising Powers’ in the global context. Globalisation and Health. 7(3).
Salter B (2011). Biomedical innovation and the geopolitics of patenting: China and the struggle for future territory. East Asian Science and Technology: An International Journal. 5:1–18
Jones M and Salter B (2010). Proceeding Carefully: assisted human reproduction policy in Canada. Public Understanding of Science. 19(4): 420-434.
Hogarth S and Salter B (2010). Regenerative medicine in Europe: global competition and innovation governance. Regenerative Medicine. 5(6): 971-85.
Filippakou O, Salter B and Tapper T (2010).Compliance, Resistance and Seduction: Reflections on 20 Years of the Funding Council Model of Governance in English Higher Education. Higher Education. 60(5): 543-557
Salter B (2010). Governing innovation in the biomedicine knowledge economy: stem cell science in the USA. Science and Public Policy 37(2): 87-100.
Salter B, Gottweis H, Waldby C (2009). The global politics of human embryonic stem cell science: regenerative medicine in transition. Basingstoke: Palgrave.
Salter B (2009). China, globalisation and health biotechnology innovation: venture capital and the adaptive state. East Asian Science and Technology: an International Journal. 3(4): 401-423.
Salter B and Qiu, R. (2009) Bioethical governance and basic stem cell science: China and the global biomedicine economy. Science & Public Policy. 36(1): 47-59.
Salter B (2009). State strategies and the global knowledge economy: the geopolitics of regenerative medicine. Geopolitics. 14: 1-31.
Fenton L and Salter B (2009). Competition and compromise in negotiating the new governance of medical performance: the clinical governance and revalidation policies in the UK. Health, Economics, Policy and Law. 4: 283-203.
Salter B (2008) Governing stem cell science in China and India: emerging economies and the global politics of innovation. New Genetics and Society. 27(2): 145-49.
Waldby C and Salter B (2008). Global Governance in Human Embryonic Stem Cell Science: Standardisation and Bioethics in Research and Patenting. Studies in Ethics Law and Technology. 2(1): 1-23.
Salter B and Harvey O (2008). Stem cell innovation in the USA: the benefits of the minimal state. Regenerative Medicine. 3(4): 597-610.
Salter B, Cooper M, Dickins A, Cardo V (2007). Stem cell science in India: emerging economies and the politics of globalisation. Regenerative Medicine. 2(1): 75-89.
Salter B (2007) ‘The global politics of human embryonic stem cell science’. Global Governance. 13: 277-98.
Salter B (2007). Bioethics and the global moral economy: the cultural politics of human embryonic stem cell science. Science, Technology and Human Values. 32(5): 1-28.
Greenaway J, Salter B, Hart S (2007). How policy networks can damage democratic health: a case study in the government of governance. Public Administration. 85(3): 1-22.
Salter B (2007). Patenting, morality and human embryonic stem cell science: bioethics and cultural politics in Europe. Regenerative Medicine. 2(3): 301-11.
Salter, B (2007) Bioethics, politics and the moral economy of human embryonic stem cell science: the case of the European Union’s Sixth Framework Programme. New Genetics and Society. 26(3).
Salter B and Jones M (2006) ‘Change in the policy community of human genetics: a pragmatic approach to open governance’. Policy and Politics. 34(2): 347-66.
Salter B, Cooper M, Dickins A (2006). ‘China and the global stem cell bioeconomy:an emerging political strategy?’. Regenerative Medicine. 1(5): 671-83.
Salter B (2006). Governing UK medical performance: a struggle for policy dominance. Health Policy. October.
Salter B and Jones M (2005) ‘Biobanks and bioethics: the politics of legitimation’. Journal of European Public Policy. 12 (4): 710-732
Salter B (2004), The New Politics of Medicine, Basingstoke, Palgrave
Greenaway J, Salter B, Hart S (2004). ‘The evolution of a “meta-policy”: the case of the Private Finance Initiative and the Health Sector’. Journal of British and International Politics. 6(4): 507-26.
Salter B and Jones M (2003) ‘The governance of human genetics: policy discourse and constructions of public trust’ New Genetics and Society. 22(1): 21-42.
Salter B (2003) ‘Patients and doctors: reformulating the UK policy community?’ Social Science and Medicine. 57: 927-36.
Frewer, L.J and Salter, B. (2003). The changing governance of biotechnology: The politics of public trust in the agri-food sector. Applied Biotechnology, Food Science and Policy, 1 (4) 199-211.
Salter B (2002) ‘Medical regulation: new politics and old power structures’ Politics vol 22(2): 59-67.
Salter B and Frewer LJ (2002) ‘Public attitudes, scientific advice and the politics of regulatory policy: the case of BSE’ Science and Public Policy 29(2): 137-45.
Salter B and Jones M (2002) ‘Human genetic technologies: European governance and the politics of bioethics’ Nature Reviews Genetics. vol 3(10): 808-14.